Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention

The aim of this study was to investigate the long-term clinical impact of residual inflammatory risk (RIR) by evaluating serial high-sensitivity C-reactive protein (hs-CRP) in Asian patients with coronary artery disease (CAD). We evaluated 2032 patients with stable CAD undergoing percutaneous corona...

Full description

Bibliographic Details
Main Authors: Norihito Takahashi, Tomotaka Dohi, Hirohisa Endo, Takehiro Funamizu, Hideki Wada, Shinichiro Doi, Yoshiteru Kato, Manabu Ogita, Iwao Okai, Hiroshi Iwata, Shinya Okazaki, Kikuo Isoda, Katsumi Miyauchi, Kazunori Shimada
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/4/1033
id doaj-951fbbb6366f46c2a8730c7846cfc962
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Norihito Takahashi
Tomotaka Dohi
Hirohisa Endo
Takehiro Funamizu
Hideki Wada
Shinichiro Doi
Yoshiteru Kato
Manabu Ogita
Iwao Okai
Hiroshi Iwata
Shinya Okazaki
Kikuo Isoda
Katsumi Miyauchi
Kazunori Shimada
spellingShingle Norihito Takahashi
Tomotaka Dohi
Hirohisa Endo
Takehiro Funamizu
Hideki Wada
Shinichiro Doi
Yoshiteru Kato
Manabu Ogita
Iwao Okai
Hiroshi Iwata
Shinya Okazaki
Kikuo Isoda
Katsumi Miyauchi
Kazunori Shimada
Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention
Journal of Clinical Medicine
hs-CRP
residual risk
biomarker
inflammation
coronary artery disease
percutaneous coronary intervention
author_facet Norihito Takahashi
Tomotaka Dohi
Hirohisa Endo
Takehiro Funamizu
Hideki Wada
Shinichiro Doi
Yoshiteru Kato
Manabu Ogita
Iwao Okai
Hiroshi Iwata
Shinya Okazaki
Kikuo Isoda
Katsumi Miyauchi
Kazunori Shimada
author_sort Norihito Takahashi
title Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention
title_short Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention
title_full Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention
title_fullStr Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention
title_full_unstemmed Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention
title_sort residual inflammation indicated by high-sensitivity c-reactive protein predicts worse long-term clinical outcomes in japanese patients after percutaneous coronary intervention
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2020-04-01
description The aim of this study was to investigate the long-term clinical impact of residual inflammatory risk (RIR) by evaluating serial high-sensitivity C-reactive protein (hs-CRP) in Asian patients with coronary artery disease (CAD). We evaluated 2032 patients with stable CAD undergoing percutaneous coronary intervention (PCI) with serial hs-CRP measurements (2 measurements, 6–9 months apart) from the period 2000 to 2016. A high-RIR was defined as hs-CRP > 0.9 mg/L according to the median value. Patients were assigned to four groups: persistent-high-RIR, increased-RIR, attenuated-RIR, or persistent-low-RIR. Major adverse cardiac events (MACE) and all-cause death were evaluated. MACE rates in patients with persistent high, increased and attenuated RIR were significantly higher than in patients with persistent low RIR (<i>p</i> < 0.001). Moreover, the rate of all-cause death was significantly higher among patients with persistent high and increased RIR than among patients with attenuated and persistent low RIR (<i>p</i> < 0.001). After adjustment, the presence of persistent high RIR (hazard ratio (HR) 2.22; 95% confidence interval (CI) 1.37–3.67, <i>p</i> = 0.001), increased RIR (HR 2.25, 95%CI 1.09–4.37, <i>p</i> = 0.029), and attenuated RIR (HR 1.94, 95%CI 1.14–3.32, <i>p</i> = 0.015) were predictive for MACE. In addition, presence of persistent high RIR (HR 2.07, 95%CI 1.41–3.08, <i>p</i> < 0.001) and increased RIR (HR 1.94, 95%CI 1.07–3.36, <i>p</i> = 0.029) were predictive for all-cause death. A high RIR was significantly associated with MACE and all-cause death among Japanese CAD patients. An evaluation of changes in inflammation may carry important prognostic information and may guide the therapeutic approach.
topic hs-CRP
residual risk
biomarker
inflammation
coronary artery disease
percutaneous coronary intervention
url https://www.mdpi.com/2077-0383/9/4/1033
work_keys_str_mv AT norihitotakahashi residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT tomotakadohi residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT hirohisaendo residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT takehirofunamizu residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT hidekiwada residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT shinichirodoi residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT yoshiterukato residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT manabuogita residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT iwaookai residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT hiroshiiwata residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT shinyaokazaki residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT kikuoisoda residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT katsumimiyauchi residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
AT kazunorishimada residualinflammationindicatedbyhighsensitivitycreactiveproteinpredictsworselongtermclinicaloutcomesinjapanesepatientsafterpercutaneouscoronaryintervention
_version_ 1724864320837255168
spelling doaj-951fbbb6366f46c2a8730c7846cfc9622020-11-25T02:21:57ZengMDPI AGJournal of Clinical Medicine2077-03832020-04-0191033103310.3390/jcm9041033Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary InterventionNorihito Takahashi0Tomotaka Dohi1Hirohisa Endo2Takehiro Funamizu3Hideki Wada4Shinichiro Doi5Yoshiteru Kato6Manabu Ogita7Iwao Okai8Hiroshi Iwata9Shinya Okazaki10Kikuo Isoda11Katsumi Miyauchi12Kazunori Shimada13Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiology, Juntendo University Shizuoka Hospital, 1129 nagaoka, Izunokuni-shi 410-2295, Shizuoka, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiology, Juntendo University Shizuoka Hospital, 1129 nagaoka, Izunokuni-shi 410-2295, Shizuoka, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanDepartment of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, JapanThe aim of this study was to investigate the long-term clinical impact of residual inflammatory risk (RIR) by evaluating serial high-sensitivity C-reactive protein (hs-CRP) in Asian patients with coronary artery disease (CAD). We evaluated 2032 patients with stable CAD undergoing percutaneous coronary intervention (PCI) with serial hs-CRP measurements (2 measurements, 6–9 months apart) from the period 2000 to 2016. A high-RIR was defined as hs-CRP > 0.9 mg/L according to the median value. Patients were assigned to four groups: persistent-high-RIR, increased-RIR, attenuated-RIR, or persistent-low-RIR. Major adverse cardiac events (MACE) and all-cause death were evaluated. MACE rates in patients with persistent high, increased and attenuated RIR were significantly higher than in patients with persistent low RIR (<i>p</i> < 0.001). Moreover, the rate of all-cause death was significantly higher among patients with persistent high and increased RIR than among patients with attenuated and persistent low RIR (<i>p</i> < 0.001). After adjustment, the presence of persistent high RIR (hazard ratio (HR) 2.22; 95% confidence interval (CI) 1.37–3.67, <i>p</i> = 0.001), increased RIR (HR 2.25, 95%CI 1.09–4.37, <i>p</i> = 0.029), and attenuated RIR (HR 1.94, 95%CI 1.14–3.32, <i>p</i> = 0.015) were predictive for MACE. In addition, presence of persistent high RIR (HR 2.07, 95%CI 1.41–3.08, <i>p</i> < 0.001) and increased RIR (HR 1.94, 95%CI 1.07–3.36, <i>p</i> = 0.029) were predictive for all-cause death. A high RIR was significantly associated with MACE and all-cause death among Japanese CAD patients. An evaluation of changes in inflammation may carry important prognostic information and may guide the therapeutic approach.https://www.mdpi.com/2077-0383/9/4/1033hs-CRPresidual riskbiomarkerinflammationcoronary artery diseasepercutaneous coronary intervention